[Clinical aspects and treatment of primary focal segmental glomerulosclerosis and hyalinosis]. / Klinika i lechenie pervichnogo fokal'nogo segmentarnogo glomeruloskleroza i gialinoza.
Vrach Delo
; (3): 82-4, 1989 Mar.
Article
em Ru
| MEDLINE
| ID: mdl-2750133
ABSTRACT
The authors studied the clinico-laboratory values and efficacy of pathogenetic treatment in 8 patients with primary segmental glomerulosclerosis and hyalinosis (PSGH). The disease is characterized by distinct disorders in the T-system immunity. Glucocorticoid treatment did not essentially effect the course of PSGH. Cyclophosphane treatment allowed to achieve essential stable clinical improvement in certain patients.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Glomerulosclerose Segmentar e Focal
/
Glomerulonefrite
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
Idioma:
Ru
Ano de publicação:
1989
Tipo de documento:
Article